ABSTRACT The foxd1 gene (previously known as Brain Factor 2/BF2) is expressed during early Xenopus laevis development. At gastrula stages, foxd1 is expressed in dorsal mesoderm regions fated for muscle and notochord, while at neurula stages, foxd1 is expressed in the forebrain region. Previous studies in the neural plate showed that FoxD1 protein acts as transcriptional repressor downstream of BMP antagonism, neuralizing the embryo to control anterior neural cell fates. FoxD1 mesoderm function was not rigorously analyzed, but ectopic FoxD1 levels increased muscle marker expression in embryos. Using a FoxD1-specific antisense morpholino oligonucleotide, we knocked down endogenous FoxD1 protein activity in developing Xenopus embryos. In this present study, we show that FoxD1 is crucial for dorsal mesoderm formation. Analogous to neural tissue, FoxD1 acts downstream of BMP antagonism to induce dorsal mesoderm cell fates, such as muscle and notochord. FoxD1 is sensitive to its local signaling environment, having differential transcription factor activity in the presence or absence of Wnt or BMP signaling. FoxD1 induces posterior neural tissue in the presence of Wnt or BMP activities, but its activity is restricted to "normal" anterior neural tissue induction when BMP and Wnt activities are repressed. In dorsal mesoderm, FoxD1 interacts with Wnt signaling and BMP antagonism to induce muscle and notochord, while simultaneously repressing more anterior and ventral mesoderm cell fates. FoxD1 protein has multiple activities that are masked or released in the different germ layers as a function of the local signaling environment.
Introduction
Pattern formation during early embryo development is dependent on an intricate relationship between signaling pathways and transcription factors (Gerhart, 2015) . Signaling pathways can nonautonomously induce expression of transcription factors in adjacent cells, which will then autonomously control that cell's specific fate. In turn, transcription factors can induce expression of downstream signaling ligands that act non-autonomously on neighboring cells to alter their fate from that of their adjacent inducing neighbor. During early development, apparent redundant expression of signaling pathways and transcription factors is widespread throughout and within the developing germ layers, yet despite this apparent overlap in expression or activities, cells manage to sort this information out, and differentiate correctly. Understanding how similar signals lead to different cell fate outcomes has been enigmatic to elucidate dur-the role for FoxD1 at neurula stages. Utilizing ectopic expression of FoxD1 hypermorph and antimorph proteins, FoxD1 was shown to act as a transcriptional repressor that has strong neuralizing activity (Mariani and Harland, 1998) . In Xenopus animal cap (AC) explants, foxd1 expression is activated by BMP antagonists; subsequently, FoxD1 activates downstream expression of panneural and anterior markers by repressing bmp4 gene expression (Mariani and Harland, 1998) . Ectopic FoxD1 neuralizes embryos, and expands expression of panneural markers; while more differentiated subtypes of cells, such as primary neurons and neural crest are reduced (Mariani and Harland, 1998) . Ectopic FoxD1-VP16 antimorph protein levels inhibit neural marker expression in embryos (Mariani and Harland, 1998) . In AC explants, ectopic FoxD1 levels induced panneural and forebrain marker expression, which might be expected for a neural inducing factor acting downstream to BMP antagonism. Somewhat counterintuitively, ectopic FoxD1 also induced expression of more posterior hindbrain and spinal cord neural markers (Wallingford and Harland, 2001; Borchers et al., 2008; Fonar et al., 2011) . These ACs also underwent neural convergent extension morphogenesis that is associated with hindbrain and spinal cord fates (Wallingford and Harland, 2001; Borchers et al., 2008; Fonar et al., 2011) . It is somewhat puzzling that a forebrain-specific protein like FoxD1 can efficiently induce posterior neural cell fates in these explants. However, our previous studies partially explain this enigma. In AC explants neuralized by FoxD1, wnt3a gene expression is induced; this Wnt-activity is required for neural caudalization by FoxD1 (Fonar et al., 2011) .
To further advance our understanding of FoxD1 function in neural and mesoderm patterning, we examined the interaction of FoxD1 protein with the canonical Wnt and BMP pathways. These pathways have crucial roles in both mesoderm and neural patterning (Kimelman, 2006; . We found that FoxD1 acts as a strong inducer of anterior neural fates in embryos and explants depleted of canonical Wnt signaling, versus controls. This is typical of the forebrain region, where Wnt activity is low, and the foxd1 gene is normally expressed. FoxD1 cannot induce posterior neural markers in the absence of Wnt signaling. In the mesoderm, we show that FoxD1 protein is required for muscle and notochord fates, while concomitantly repressing ventral and anterior fates. BMP antagonism activates foxd1 expression in dorsalized mesoderm explants. In dorsalized explants, FoxD1 protein acts downstream of BMP antagonism to induce dorsal mesoderm fates, similar to its role as a mediator of BMP antagonism in the neural plate. FoxD1 requires canonical Wnt activity to induce muscle in the dorsal lateral mesoderm, but not notochord in the more dorsal regions where Wnt signaling is normally inhibited and low. Thus, in both neural and mesoderm tissue, FoxD1 acts downstream to BMP antagonism to differentially pattern tissue fates via canonical Wnt signaling.
Results

FoxD1 has enhanced anterior neural inducing activity in the absence of canonical Wnt-signaling
To address FoxD1/Wnt interplay, we examined embryos (Fig. 1A ) co-expressing ectopic FoxD1 and Dkk1 proteins. Ectopic FoxD1 expression alone gives the typical neuralized phenotype (Fig.  1B) , whereas ectopic expression of Dkk1 gives a representative anteriorized phenotype with a shortened-truncated body axis having an enlarged head and cement gland (Fig. 1C) . However upon co-expression of both proteins, the embryos lost all axial structure, having a highly anteriorized body plan, with a radial cement gland (Fig 1D) . Thus, ectopic FoxD1 activity strongly enhanced neural anteriorization induced by Dkk1 protein.
Similar results were seen in AC explants. FoxD1 induces expression of wnt3a in ACs and this downstream Wnt activity seems to mediate FoxD1 activation of posterior neural markers in ACs (Fonar et al., 2011) . ACs that express ectopic FoxD1 alone activate a representative group of neural markers expressed along the anteroposterior (AP), as well as panneural markers (Fig. 2A, lane 4) . In ACs, ectopic FoxD1 and Dkk1 protein levels increased anterior xanf1, xag1 and otx2 marker expression ( Fig. 2A , lane 4 versus 6), whereas expression of the more posterior krox20, hoxb9 and n-tub markers is highly reduced (Fig. 2A, lane 4 versus 6) . Expression of the panneural markers, nrp1 and ncam is unchanged (Fig. 2A , lane 4 versus 6), These results show that FoxD1 does not require Wnt signaling for general neural induction, just neural patterning. Dkk1 alone does not significantly modulate neural marker expression in ACs ( Fig. 2A, lane 5) .
In reciprocal experiments, Wnt3a was ectopically co-expressed with FoxD1 protein in ACs. Anterior marker expression (xanf1, xag1, otx2) induced by FoxD1 was repressed; posterior neural marker expression was enhanced (krox20, hoxb9); and panneural marker (ncam and nrp1) expression was unaltered (Fig. 2B , compare lane 4 versus 6). Under these experimental conditions, ectopic Wnt3a expression alone did not strongly activate expression of posterior neural markers, but only enhanced their expression in the presence of FoxD1 protein (Fig. 2B , compare lanes 4-6). Ectopic FoxD1 induces moderate elongation of ACs, typical of posterior neural convergent extension cell movements (Wallingford and Harland, 2001) . In a typical representative experiment, FoxD1 induces moderate-strong elongations in about 15% of the explants, whereas FoxD1/Wnt3a co-expression enhances elongations about four fold to about 60% (not shown). In comparison, FoxD1/Dkk1 FoxD1 caudalizing activity can be uncoupled from neural induction in animal cap explants Foxd1 and BMP4 proteins were co-expressed to determine if FoxD1 acts independently of neural induction to activate posterior neural marker expression. At early neurula stages, xanf1/otx2 (forebrain), gbx2 (hindbrain), n-tub (primary neuron) and ncam (panneural) gene expression was induced by FoxD1 in ACs (Fig. 3A , lane 4). Hoxb9 and cdx1 markers (spinal cord) were not detected at this stage (Fig. 3A, lane 4) . Co-expression of BMP eliminated neural induction, as measured by ncam and xanf1 expression (Fig. 3A , lane 4 versus 6). BMP was permissive for gbx2 and n-tub expression, while stimulating the more posterior hoxb9 and cdx1 expression (Fig. 3A , lane 4 versus 6). BMP4 alone did not significantly induce posterior neural markers at these concentrations (Fig. 3A, lane 5) . Similar results were also seen in late neurula stage AC explants. FoxD1 induced expression of xanf1, otx2, xag1, hoxb9, cdx1, cdx4 and ncam (Fig. 3B, lane 4) . Ectopic BMP enhanced FoxD1 induction of spinal cord specific cdx1, cdx4 and hoxb9 expression, while repressing xanf1, otx2, xag1 and ncam expression levels (Fig. 3B , lane 4 versus 6). BMP alone did not induce hoxb9, cdx1 or cdx4 expression (Fig. 3B, lane 5) . These results show that FoxD1 has an intrinsic ability to induce expression of posterior neural markers when uncoupled from neural induction mediated by BMP antagonism, presumably by its ability to activate Wnt signaling via induction of wnt3a gene expression (Fonar et al., 2011) . Neural uncoupled induction of posterior neural markers has been shown in naïve ACs for other proteins, like Wnt3a or the TALE-class homeobox protein Meis3, which activates posterior markers downstream to Wnt signaling in the absence of activating panneural marker expression (Dibner et al., 2001; . In Xenopus, foxd1 gene expression Fig. 2 
FoxD1 protein knockdown reduces neural and dorsal mesoderm cell fates
To further investigate function in Xenopus, FoxD1 protein was knocked down by the FoxD1-MO. Previous loss-of-function studies is restricted to the forebrain region. This region is characterized by a strong inhibition of canonical Wnt and BMP signaling (Niehrs et al., 2001) . Thus under normal physiological conditions, FoxD1 is primed to induce anterior neural tissue. In AC explants permissive for BMP and canonical Wnt activities, intrinsic FoxD1 neural caudalizing is unmasked, which is not in the correct cellular context of normal FoxD1 protein function and activity in vivo. These results (Mariani and Harland, 1998) . All AP neural fates were perturbed in FoxD1 morphant embryos. Using both sqRT-PCR (not shown) and in situ hybridization, we detected large reductions in expression of the anterior otx2 (forebrain) marker, as well a reduction of more posterior krox20 (hindbrain) and hoxb9 (spinal cord) markers (Fig. 4A , left versus right panel), Expression of the panneural ncam marker was also reduced (not shown). These results recapitulated the FoxD1 antimorph protein (Mariani and Harland, 1998) . The reduction of posterior neural markers like hoxb9 and krox20 is presumably due to the overall reduction in general neural cell fates, similar to the previously reported loss of neural crest and primary neuron fates induced by FoxD1 antimorph protein (Mariani and Harland, 1998 (Fig. 4C) . At later neural stages, we also see a reduction in notochord markers such as, chordin and xnot (not shown), and muscle markers such as myod (not shown) and MA (Fig. 4D) . Typically, notochord markers are less dramatically reduced versus muscle markers. Ectopic FoxD1-VP16 antimorph protein inhibited neural marker expression in Xenopus embryos (Mariani and Harland, 1998) . Similar to the FoxD1-MO, ectopic FoxD1-VP16 antimorph protein also reduced expression levels of dorsal mesoderm markers in gastrula (not shown) and neurula stage embryos (Fig. 4E) . As a control for FoxD1-MO specificity, we demonstrate that ectopically expressed FoxD1 protein can rescue the loss of myod and ncam expression in FoxD1 morphant embryos (Fig. 4F) . (Gómez-Skarmeta et al., 1999 ; not shown), but not in the ventral marginal zone (VMZ). To address a role for FoxD1 in mesoderm dorsalization, we ectopically expressed FoxD1 protein in VMZ explants. FoxD1 induced expression of both muscle (muscle actin-MA, myod) and notochord (xnot, chd) markers in these explants (Fig. 5A) . Expression of the ventral marker vent1 was repressed by ectopic FoxD1 activity (Fig. 5A) . These VMZ explants also underwent convergent extension elongations characteristic of dorsal muscle and notochord, but not ventral tissue (Fig. 5B) . The ectopic activation of notochord and muscle markers and the induced explant elongations demonstrates that FoxD1 protein re-specifies ventral tissue to dorsal fates.
morphants, otx2 expression was reduced in 100% of the embryos (n=19); krox20 expression was reduced in either one or both rhombomeres in 69% of the embryos (n=13), and hoxb9 expression was inhibited in 77% of the embryos (n=13). (B) One-cell stage embryos were injected marginally with the FoxD1-MO (25 ng). Total RNA was isolated from pools of five control (lane 2) or FoxD1 morphant embryos (lane 3) at late neurula stages. sqRT-PCR was carried out to mesoderm markers expressed along the dorso-ventral axis
During gastrula stages, BMP antagonists secreted from the DMZ dorsalize ventral mesoderm to dorsal-lateral fates like muscle (Harland and Gerhart, 1997; De Robertis et al., 2000) . Noggin treatment of VMZ explants induces muscle formation and convergent extension (Smith et al., 1993; Re'em-Kalma et al., 1995) . Analogous to Noggin treated ACs (Mariani and Harland, 1998) , foxd1 gene expression is also induced in Noggin dorsalized VMZs (Fig. 5C, lane 4 versus 6 ). To address a role for FoxD1 in this dorsalizing assay, the FoxD1-MO was injected into Noggin treated VMZs. In these explants, there was a strong reduction in the induction of muscle and notochord marker expression (Fig. 5C , lane 6 versus 7) and a reduction in explant elongations (Fig. 5B) . Endogenous FoxD1 protein is also required for Noggin to activate foxd1 gene expression (Fig. 5C, lane 6 versus  7) . In parallel, the FoxD1-MO increased expression of ventral markers (vent1, wnt8) in the VMZs (Fig. 5C , lane 4 versus 5, lane 6 versus 7), suggesting that endogenous levels of FoxD1 protein act in the mesoderm to actively repress ventral cell fates at the dorsal-lateral/ventral border regions. FoxD1 protein acts 
was isolated from six control embryos (lane 2), and from eighteen VMZs from each group (lanes 3-6). Expression of the xnot and MA markers was examined by sqRT-PCR. (B) Embryos were injected marginally at the one-cell stage with mRNA encoding the noggin (20 pg) and dkk1 (40 pg) proteins. Embryos were than co-injected with either mRNA encoding the foxd1 (30 pg) protein or the FoxD1-MO (45 pg). VMZ explants were removed from control and injected embryos at gastrula stage 10.25, and VMZs were cultured to neurula stage 17. Total RNA was isolated from six control embryos (lane 2), and from eighteen DLMZs from each group (lanes 3-6). Expression of the anterior (gsc, nkx2.5), dorsal (chd), and dorsal lateral (MA) markers was examined by sqRT-PCR. (C) Embryos were injected marginally at the one-cell stage with mRNA encoding the foxd1 (25 pg) and dkk1 (40 pg). DLMZ explants were removed from control and injected embryos at gastrula stage 10.25, and cultured to neurula stage 17. Total RNA was isolated from six control embryos (lane 2), and from eighteen DLMZs from each group (lanes 3-6). Expression of the anterior (gsc,nkx2.5), dorsal (chd, xnot), and dorsal lateral (myod) markers was examined by sqRT-PCR. (D) Embryos were injected marginally at the one-cell stage with mRNA encoding the noggin (20 pg) and dkk1 (40 pg) proteins. Embryos were than co-injected with either mRNA encoding the foxd1 (30 pg) protein or the FoxD1-MO (45 pg). DLMZ explants were removed from control and injected embryos at gastrula stage 10.25, and DLMZs were cultured to neurula stage 17. Total RNA was isolated from six control embryos (lane 2), and from eighteen DLMZs from each group (lanes 3-7). Expression of the anterior (gsc), dorsal (chd, xnot), and dorsal lateral (MA) markers was examined by sqRT-PCR.
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downstream to BMP antagonism to regulate dorsal mesoderm formation. Similar results were seen in noggin treated DLMZ explants. Noggin reduced muscle but increased more dorsal notochord marker expression in these explants (Fig. 5D , lane 3 versus 4) The FoxD1-MO strongly reduced noggin induction of notochord marker expression (Fig. 5D, lane 4 versus 5) . In noggindorsalized DLMZs, FoxD1 knockdown triggered expression of the more anterior heart specific nkx2.5 marker (Fig. 5D, lane 5) suggesting that in dorsal mesoderm, FoxD1 actively represses expression of genes that promote more anterior heart fates. In further support, FoxD1 morphant DLMZs undergo significantly less elongation versus control DLMZs (Fig. 5B) , likely due to the loss of muscle and notochord fates.
FoxD1 and Wnt signaling interact to regulate dorsal-ventral mesoderm patterning
In Xenopus and other vertebrates, early zygotic Wnt signaling has been shown to be required for muscle formation (Christian and Moon, 1993; Hoppler et al., 1996; Hoppler and Moon, 1998; Lekven et al., 2001) . Wnt8 is expressed in the most ventral mesoderm (Smith and Harland, 1991) , and Wnt antagonists are expressed in the more dorsal-anterior regions (Cruciat and Niehrs, 2013) , suggesting that in the DLMZ, an intermediate level of Wnt signaling is required for muscle formation. We determined if FoxD1 requires Wnt signaling to induce dorsal cell fates. FoxD1 and the canonical Wnt inhibitor Dkk1 were co-expressed in VMZs. In this assay FoxD1 poorly induces muscle and notochord markers (Fig. 6A) ; however, notochord markers tend to be less inhibited than muscle markers, since muscle specification is more sensitive to the loss of Wnt-signaling than the more dorsal notochord. Unlike noggin, which dorsalizes the VMZ, Dkk1 alone does not significantly dorsalize or anteriorize VMZ cell fates (Fig. 6A ) nor induce elongation movements (Fig. 5B) . To further address this point, VMZs were dorso-anteriorized by the ectopic co-expression of both Noggin and Dkk1 proteins. Under these conditions, the more anterior gsc and nkx2.5 markers were expressed along with muscle and notochord markers (Fig 6B, lane 3 versus 4) . The gsc gene is expressed in the most anterior prechordal mesoderm and is only expressed in VMZ and DLMZ explants when Wnt signaling is inhibited by Dkk1 protein expression (Figs. 6 B-D) . When these anteriorized explants are knocked down for FoxD1 protein by the FoxD1-MO, nkx2.5 and gsc expression is increased, or maintained at high levels, yet chd and MA levels are reduced (Fig. 6B, lane 4 versus 5) . Reciprocally, when ectopic FoxD1 protein was expressed in these anteriorized explants, chd and MA was increased, but gsc and nkx2.5 expression were strongly inhibited (Fig. 6B, lane 4 versus 6) . These results again suggest that FoxD1 maintains muscle and notochord fates by repressing both anterior and ventral fates (Fig. 4B, 5 A-C) .
To gain a more thorough understanding of the role of FoxD1/ Wnt signaling interactions in mesoderm patterning, we performed experiments on DLMZ explants fated for notochord and muscle that were anteriorized by ectopic Dkk1 protein expression. Unlike VMZs, DLMZs are specified to dorsal fates. In the DLMZs, ectopic FoxD1 protein expression enhanced notochord marker expression, but had a less profound effect on muscle markers, presumably because muscle is at saturation levels in the DLMZ, whereas notochord is not (Fig. 6C, lane 3 versus 4) . Ectopic Dkk levels enhanced expression of the more anterior pre-chordal gsc and heart nkx2.5 markers; notochord markers were also increased, but muscle marker expression was reduced (Fig. 6C,  lane 3 versus 5) . Co-expression of FoxD1 and Dkk1 proteins caused a reduction in anterior marker expression, notochord markers were maintained, but muscle marker expression was not rescued (Fig. 6C, lane 5 versus 6) . Inhibition of Wnt signaling is permissive for the most anterior and dorsal fates, but not for the more lateral muscle. Ectopic levels of FoxD1 and Dkk1 proteins inhibited anterior marker expression, maintained notochord levels, but could not rescue muscle fates, due to low Wnt signaling. Thus in the DLMZ, FoxD1 can maintain notochord cell fates, but not muscle cell fates in the absence of Wnt signaling.
To further elucidate FoxD1/Wnt signaling interactions, DLMZ explants fated for notochord and muscle were dorso-anteriorized by ectopic co-expression of both Noggin and Dkk1 proteins (Fig. 6D) . In the DLMZs, FoxD1 protein knock down, enhances basal levels of gsc expression, while reducing expression of notochord and muscle markers (Fig. 6D, lane 3 versus 4) . Ectopic levels of Noggin and Dkk1 proteins strongly increased gsc levels, moderately increased chd and xnot levels, while MA levels are slightly reduced (Fig. 6D, lane 3 versus 5 ). Noggin and Dkk1 push mesoderm cells to more dorsal-anterior fates (prechordal and notochord), away from the more lateral muscle. When FoxD1 protein is knocked down, gsc expression is further enhanced, while notochord and muscle markers are reduced (Fig.  6D , lane 5 versus 6). In contrast, when FoxD1 protein is ectopically expressed, gsc expression is reduced and notochord and muscle markers are increased (Fig. 6D , compare lane 5 versus 7). Interestingly in a manner similar to the anterior gsc marker residual expression levels of the vent1 gene in DLMZ explants were further repressed by ectopic FoxD1 protein expression and increased by FoxD1 protein knockdown (not shown). These results again demonstrate how FoxD1 protein actively represses both anterior and ventral mesoderm fates, while simultaneously promoting dorsal and dorsal-lateral and cell fates.
Discussion
There are over forty different forkhead box/Fox genes in the vertebrate genome. This gene family is subdivided into 19 subfamilies, A -S, based amino acid variations within the forkhead box domain (Yaklichken et al., 2007; Shimeld et al., 2010) . These proteins play diverse roles in early vertebrate development, and Fox gene family mutations have also been associated with a number of human genetic diseases (Hannenhalli and Kaestner, 2009; Benayoun et al., 2011) . These proteins have a highly conserved Fox helix-turn-helix DNA binding site, but are poorly conserved outside this Fox domain. Fox family proteins interact with a large number of different proteins that regulate gene expression, mainly acting as transcriptional repressors, but Fox proteins also act as activators in some cellular contexts (Yaklichken et al., 2007; Benayoun et al., 2011) .
In chick and mouse embryos, FoxD1 protein regulates kidney organogenesis (Hatini et al., 1996; Levinson et al., 2005; Fetting et al., 2014) , and retina formation (Herrera et al., 2004; Takahashi et al., 2009; Carreres et al., 2011) . In Xenopus laevis embryos, FoxD1 protein regulates early nervous system specification and patterning (Mariani and Harland, 1998) . During early Xenopus development, the foxd1 gene is expressed in gastrula stage dorsal mesoderm fated for muscle and notochord. Only at later neurula stages does foxd1 gene expression become restricted to anterior forebrain neural tissue (Mariani and Harland, 1998; Gómez-Skarmeta et al., 1999) . Little was known about FoxD1 mesoderm function, except that ectopic expression of FoxD1 protein increased muscle marker levels in Xenopus embryos (Gómez-Skarmeta et al., 1999) . At later stages, FoxD1 functions as a transcriptional repressor in Xenopus, to mediate neural induction and patterning downstream of BMP antagonism (Mariani and Harland, 1998) . The FoxD1 antimorph protein prevented neural tissue formation in Xenopus embryos and wild type or antimorph protein over expression reciprocally neuralized embryos (Mariani and Harland, 1998) . Somewhat surprisingly, in naïve AC ectoderm assays, ectopic FoxD1 not only induced expression of panneural and anterior neural markers, but also induced expression of more posterior hindbrain and spinal cord markers (Wallingford and Harland, 2001; Borchers et al., 2008; Fonar et al., 2011) . Moreover, these explants undergo neural convergent extension morphogenesis characteristic of hindbrain and spinal cord cells (Wallingford and Harland, 2001; Borchers et al., 2008; Fonar et al., 2011) . FoxD1 activates wnt3a gene expression in ACs, which appears to be required for the induction of posterior neural markers (Fonar et al., 2011) .
Zygotic canonical Wnt signaling regulates neural AP and mesodermal dorso-ventral (DV) patterning events during early development (Kimelman, 2006; . Since the foxd1 gene is expressed in early mesoderm and neural tissues, we examined the interaction between FoxD1 protein and Wnt signaling in regulating both neural AP and mesodermal DV patterning. Our initial observation found that in embryos lacking canonical Wnt signaling (ectopic Dkk1 expression) that co-express FoxD1 protein, there was a strong neural anteriorization phenotype that was markedly more extreme than embryos expressing either ectopic FoxD1 or Dkk1 protein alone. This result suggests that in a Wnt-depleted environment, FoxD1 acts more strongly to induce anterior neural tissue. This observation was further confirmed in AC explants. In ACs co-expressing FoxD1 and Dkk1 proteins, there was a sharp increase in anterior neural marker expression, with a parallel decrease in posterior neural marker expression, versus ACs solely expressing ectopic FoxD1. This result suggests that FoxD1 only activates posterior neural markers in regions where canonical Wnt activity is high. This ability of FoxD1 to induce posterior neural markers was uncoupled from its neural inducing activity. In the presence of ectopic BMP activity that inhibits neural induction (blocking panneural and anterior neural marker expression), FoxD1 induced expression of hindbrain and spinal cord markers. Under these conditions, FoxD1 enhanced spinal cord marker expression in the presence of BMP signaling. This uncoupling of "general" neural induction from posterior neural induction/patterning has been shown for other neural caudalizing proteins, like Wnt3a and Meis3 in naïve ACs (Salzberg et al., 1999; . In reciprocal experiments in ACs co-expressing FoxD1 and Wnt3a proteins, anterior neural marker expression is sharply decreased, with a parallel increase in posterior neural marker expression versus ACs solely expressing ectopic FoxD1. However, in Xenopus embryos, normal foxd1 expression is restricted to the forebrain region, where BMP and Wnt signaling levels are at their lowest (Fig. 7B) , being repressed by endogenous antagonist proteins (Niehrs et al., 2001) . Thus, the FoxD1 protein can multitask to pattern neural tissue along the AP axis. However under the physiological restraints of its normal rostral expression domain, it will act as a neural anteriorizer. Yet, if given the proper non-physiological environment, with high Wnt levels, FoxD1 neural caudalizing activity is unmasked.
Analogous observations were seen for an earlier role of FoxD1 protein in dorsal mesoderm specification and patterning. Similar to anterior neural tissue, FoxD1 expression is activated by BMP antagonists and FoxD1 is required downstream to BMP antagonism for proper muscle and notochord formation. In FoxD1 morphant embryos, there is a sharp loss of both muscle and notochord cell 
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FoxD1/signaling pathway interactions pattern the embryo 301 fates. However, unlike FoxD1 forebrain inducing activity in the nervous system which acts independently of Wnt signaling, Wnt activity is required for FoxD1 regulation of muscle formation in the mesoderm. Thus in addition to BMP antagonism, canonical Wnt signaling acts with FoxD1 protein to induce muscle. This requirement for Wnt signaling is not as strict for regulation of the more dorsal notochord tissue. In addition to promoting muscle and notochord cell fates, FoxD1 also functions to repress cell fates in these regions. In more ventral regions, in the DLMZ/VMZ border region, where Wnt signaling is higher and required for muscle formation, FoxD1 acts to repress ventral cell fates (Fig. 7B) . In the more dorsal/anterior border regions, where Wnt signaling is low, FoxD1 represses anterior fates (prechordal, heart) to promote notochord formation (Fig 7B) .
Thus in the mesoderm, FoxD1 acts downstream to BMP antagonism and utilizes varying Wnt levels to direct cells to different fates along the antero-posterior and dorso-ventral axes. FoxD1 acts as a multifunctional protein that interacts differentially to its cellular signaling environment to "fine tune" and promote cell fates in the different germ layers. In neural tissue, its global activity, which includes activating posterior cell fates via wnt3a gene activation (Fonar et al., 2011) , is restricted to anterior neuralizing activity, because in vivo, the protein is expressed in a low-Wnt, low-BMP embryonic regions. In the mesoderm, the FoxD1 is expressed in regions with varying Wnt levels and low BMP activities, where it differentially promotes dorsal mesoderm fates, while repressing ventral and anterior fates.
We have not pinpointed if FoxD1 is directly modifying Wnt or BMP target genes, or whether its effects are more indirect. Fox proteins do interact with the Groucho repressor protein, and Groucho directly interacts with the transcriptional machinery mediating the Wnt and Nodal signaling pathways (Daniels and Weis, 2005 , Yaklichken et al., 2007 , Reid et al., 2016 . In the absence of Wnt signaling, FoxD1 proteins could potentially be part of a complex directly repressing Wnt target genes in anterior neural or dorsal mesodermal regions. Another possibility is that the activation/ antagonism of Wnt or BMP signaling modifies the accessibility of FoxD1 protein to different chromatin domains, thus modulating its ability to repress varying target genes in specific tissues. Future experiments should determine how FoxD1 protein mediates repression of gene expression in differing signaling environments.
Our results show that the FoxD1 protein has a number of intrinsic activities that direct cell fate decisions, but they are tightly regulated by the localized signaling cues active in its region of expression. In theory, a transcription factor can have many latent activities that are only partially released in certain cellular contexts. This mode of activity could explain diverse functions for a given protein at the same developmental time, but in different tissues, for different times of development in the same organism, or even differences in function for the same protein between different species. Varying transcription factor activity as a function of a localized signaling environment could be a strong evolutionary factor that drives differential functions of the same transcription factor in a wide variety of tissues and species. Essentially, the specific signaling environment in a transcription factor expression domain will determine which intrinsic function will be activated or masked. FoxD1 is a prime example of how this intricate regulation is utilized for patterning of the nervous system and mesoderm during early Xenopus development.
Materials and Methods
Xenopus embryos
Ovulation, in vitro fertilization, culture, and explant dissections and treatments were as described (Re'em-Kalma et al., 1995; Henig et al., 1998; Bonstein et al., 1999) . Explant elongations were quantitated as described (Bin-Nun et al., 2014) .
RNA, morpholino oligonucleotide (MO) injections, and plasmid constructs
Capped sense in-vitro transcribed mRNA constructs of foxd1, VP16-FoxD1 (Mariani et al., 1998 ), bmp4 (Re'em-Kalma et al., 1995 , dkk, wnt3a, and noggin, Elkouby et al., 2012) were injected into one-cell stage embryos. The sequence of the FoxD1 antisense morpholino oligonucleotide (FoxD1-MO) is: 5'-TCATGGCTTGGGAG-GCAAAGCATAA-3', (Gene Tools).
In-situ hybridization
Whole-mount in-situ hybridization was performed with digoxigeninlabeled probes (Harland, 1991) to muscle actin (MA) and myod (Keren et al., 2005) , chd (Murgan et al., 2014) , and otx2, krox20 and hoxb9 (Aamar and Frank, 2004; Gutkovich et al., 2010) .
Semi-quantitative (sq) RT-PCR analysis
sqRT-PCR was performed (Snir et al., 2006) . In all sqRT-PCR experiments, three to six independent experimental repeats were typically performed. In all experiments, samples are routinely assayed a minimum of two times for each marker. sqRT-PCR Primers: efa, odc, his4, nrp1, ncam, xanf1, otx2, xag1, krox20, gbx2, hoxb9, cdx1, cdx4, n-tub, gsc, nkx2.5, chd, xnot, foxd1, myod, muscle actin (MA), vent1, vent2, wnt8 (Zetser et al., 2001; Dibner et al., 2004; Snir et al., 2006; Gutkovich et al., 2010; , Fonar et al., 2011 , Bin-Nun et al., 2014 .
